Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute (GBAICTI), shared on LinkedIn:
“Attended a very interesting meeting as a keynote speaker immediately before heading to Seoul for International Association for the Study of Lung Cancer WCLC26!
My thanks to Rebecca Zhang from SCOR for inviting me to give a talk on medical advancements in oncology and its impact on the insurance industry at their annual APAC symposium held in DaNang.
A completely new field to me as a practicing clinician, but decisions made by actuaries and other professionals in this industry have overwhelming impact to ensure sustainability, efficiency and accessibility to oncology care.”
This also can be interesting:
Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology
